AMZN · News · 20260806N
Pharmacy GLP-1 Expansion
AMAZON COM INC · 2026-08-06 · Importance 31 · Surprise 42 · In source text
Amazon Pharmacy said it will offer certain weight-loss medications to eligible Medicare beneficiaries for $50 per month through a new federal access program. The available products include Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound and Foundayo. The program expands Amazon Pharmacy’s role in the high-demand GLP-1 market and targets Medicare Part D patients. Amazon is competing with CVS and Walmart to fill prescriptions for the more than 66 million people covered by Medicare.
Key facts
- Amazon Pharmacy will offer weight-loss drugs to eligible Medicare beneficiaries for $50 a month through a new federal Medicare program. source
- Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo will be available through Amazon Pharmacy at a cost of $50 a month. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | Amazon Pharmacy will offer weight-loss drugs to eligible Medicare beneficiaries for $50 a month through a new federal Medicare program. |